Pharmaceutical

Pharmaceutical
video

Canadian Health Minister Jane Philpott’s cheeky use of April 20 – 4/20 in pot smokers’ code – to set a one-year timeline for legalization of recreational marijuana spells an important day for the marijuana industry as a whole. Shortly after the...

Inversion deals, a controversial tax arrangement in which a business incorporates in another country to avoid paying U.S. corporate taxes, have come under fire in a new way recently.

Tempting overseas tax rates are encouraging many U.S. companies to pursue cross-border deals. A number of deal inversions have been explored or attempted in the last two years alone.

Monoclonal antibodies (mAbs) represent one of the most successful therapeutic drug classes, attracting billions of investment dollars for the biotechnology industry. Last week AstraZeneca’s global biologics research and development arm, MedImmune, became the latest mAb player. MedImmune acquired Spirogen, a privately held...

2012 was a healthy year for the U.S. pharmaceuticals industry, with 39 new drugs approved - the highest in 16 years. This trend was largely driven by a string of recent patent expirations, with generic drug makers able to offer cheaper alternatives...